{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T04:54:54Z","timestamp":1768884894642,"version":"3.49.0"},"reference-count":84,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2013,6,1]],"date-time":"2013-06-01T00:00:00Z","timestamp":1370044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["La Presse M\u00e9dicale"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1016\/j.lpm.2013.01.058","type":"journal-article","created":{"date-parts":[[2013,4,30]],"date-time":"2013-04-30T17:21:36Z","timestamp":1367342496000},"page":"e181-e192","source":"Crossref","is-referenced-by-count":30,"special_numbering":"P2","title":["Pathophysiology of autoimmune polyneuropathies"],"prefix":"10.1016","volume":"42","author":[{"given":"Marinos C.","family":"Dalakas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.lpm.2013.01.058_bib0005","series-title":"Clinical Immunology: Principles and Practice","first-page":"977","article-title":"Autoimmune peripheral neuropathies","author":"Dalakas","year":"2011"},{"key":"10.1016\/j.lpm.2013.01.058_bib0010","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMra1114525","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Yuki","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.01.058_bib0015","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1016\/S0140-6736(05)67665-9","article-title":"Guillain-Barr\u00e9 syndrome","volume":"366","author":"Hughes","year":"2005","journal-title":"Lancet"},{"issue":"1\u20132","key":"10.1016\/j.lpm.2013.01.058_bib0020","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jneuroim.2010.09.017","article-title":"Guillain-Barr\u00e9 syndrome: clinical variants and their pathogenesis","volume":"231","author":"Winer","year":"2011","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0022-510X(93)90324-R","article-title":"Severe axonal degeneration in acute Guillain-Barr\u00e9 syndrome: evidence of two different mechanisms?","volume":"116","author":"Feasby","year":"1993","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2013.01.058_bib0030","doi-asserted-by":"crossref","first-page":"11404","DOI":"10.1073\/pnas.0402391101","article-title":"Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipo-oligosaccharide causes Guillain-Barr\u00e9 syndrome","volume":"101","author":"Yuki","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2013.01.058_bib0035","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1093\/brain\/awf272","article-title":"Peripheral neuropathies and anti-glycolipid antibodies","volume":"125","author":"Willison","year":"2002","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.058_bib0040","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1471-4159.2010.07029.x","article-title":"Antibodies against ganglioside complexes in Guillain-Barr\u00e9 syndrome and related disorders","volume":"116","author":"Kusunoki","year":"2011","journal-title":"J Neurochem"},{"key":"10.1016\/j.lpm.2013.01.058_bib0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","article-title":"Medscape. Advances in the diagnosis, pathogenesis and treatment of CIDP","volume":"7","author":"Dalakas","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/jnnp.66.5.677","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south-east England","volume":"66","author":"Lunn","year":"1999","journal-title":"J Neurol Neurosurg Psychiatr"},{"key":"10.1016\/j.lpm.2013.01.058_bib0055","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1085-9489.2006.00061.x","article-title":"Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy","volume":"11","author":"Hughes","year":"2006","journal-title":"J Peripheral Nervous System"},{"key":"10.1016\/j.lpm.2013.01.058_bib0060","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/S1474-4422(10)70041-7","article-title":"Chronic inflammatory demyelinating polyradiculoneuropathy: diagnostic and therapeutic challenges for a treatable condition","volume":"9","author":"Vallat","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0065","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1212\/01.wnl.0000188879.19900.b7","article-title":"Macrophage clustering as a diagnostic marker in sural nerve biopsies of patients with CIDP","volume":"65","author":"Sommer","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0070","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1080\/019131200750060023","article-title":"Chronic inflammatory demyelinating polyneuropathy: immunopathological and ultrastructural study of peripheral nerve biopsy in 42 cases","volume":"24","author":"Vital","year":"2000","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0075","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMra041347","article-title":"Chronic inflammatory demyelinating polyneuropathy","volume":"352","author":"Koller","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.01.058_bib0080","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S1474-4422(05)70074-0","article-title":"Multifocal motor neuropathy","volume":"4","author":"Van Asseldonk","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0085","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/ana.410390402","article-title":"(Editorial) Autoimmune ataxic Neuropathies (sensory ganglionopathies): are glycolipids the responsible autoantigens?","volume":"39","author":"Dalakas","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0090","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/ana.410190605","article-title":"Chronic idiopathic ataxic neuropathy","volume":"19","author":"Dalakas","year":"1986","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0095","first-page":"301","article-title":"Peripheral neuropathy and anti-MAG antibodies","volume":"3","author":"Latov","year":"1988","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0100","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00019052-199908000-00006","article-title":"Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifiers","volume":"12","author":"Dalakas","year":"1999","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0105","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0022-510X(76)90213-6","article-title":"Chronic relapsing polyneuritis","volume":"27","author":"Prineas","year":"1976","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2013.01.058_bib0110","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/brain\/123.8.1660","article-title":"Expression of the costimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy","volume":"123","author":"Murata","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.058_bib0115","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/jnnp.69.3.362","article-title":"Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies","volume":"69","author":"Kiefer","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.058_bib0120","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1212\/01.wnl.0000250240.99311.9d","article-title":"Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies","volume":"68","author":"Hu","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0125","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1084\/jem.194.5.677","article-title":"Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice","volume":"194","author":"Salomon","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.lpm.2013.01.058_bib0130","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/WNL.0b013e318245d250","article-title":"CD8+ T-cell immunity in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"78","author":"Schneider-Hohendorf","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0135","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1529-8027.2010.00294.x","article-title":"Distribution of Th17 cells and Th1 cells in peripheral blood and cerebrospinal fluid in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"15","author":"Chi","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.058_bib0140","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1529-8027.2008.00158.x","article-title":"Impairment of circulating CD4+ CD25+ regulatory T-cells in patients with chronic infl ammatory demyelinating polyradiculoneuropathy","volume":"13","author":"Chi","year":"2008","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.058_bib0145","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3109\/08916930903140907","article-title":"Circulating subsets and CD4(+)CD25(+) regulatory T-cell function in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"42","author":"Sanvito","year":"2009","journal-title":"Autoimmunity"},{"key":"10.1016\/j.lpm.2013.01.058_bib0150","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ana.410300110","article-title":"Serum interleukin-2 concentrations in Guillain-Barr\u00e9 syndrome and chronic idiopathic emyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis","volume":"30","author":"Hartung","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0155","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1093\/brain\/awf070","article-title":"Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10","volume":"125","author":"Kieseier","year":"2002","journal-title":"Brain."},{"key":"10.1016\/j.lpm.2013.01.058_bib0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1136\/jnnp.73.3.320","article-title":"Expression of chemokines in cerebrospinal fluid and serum of patients with chronic inflammatory demyelinating polyneuropathy","volume":"73","author":"Mahad","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.058_bib0165","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-5728(93)90284-6","article-title":"Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain-Barr\u00e9 syndrome and chronic inflammatory demyelinating polyradiculoneuropathy","volume":"47","author":"Maimone","year":"1993","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0170","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.44.5.946","article-title":"Expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) in chronic inflammatory demyelinating polyneuropathy","volume":"44","author":"Oka","year":"1994","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.lpm.2013.01.058_bib0175","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.jneuroim.2004.10.021","article-title":"Gene expression profiling in chronic inflammatory demyelinating polyneuropathy","volume":"159","author":"Renaud","year":"2005","journal-title":"J Neuroimmunol"},{"issue":"1\u20132","key":"10.1016\/j.lpm.2013.01.058_bib0180","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jns.2009.10.006","article-title":"Differential gene expression in chronic inflammatory demyelinating polyneuropathy (CIDP) skin biopsies","volume":"290","author":"Lee","year":"2010","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2013.01.058_bib0185","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1002\/ana.410380214","article-title":"Acute axonal Guillain-Barr\u00e9 syndrome with IgG antibodies against motor axons following parenteral gangliosides","volume":"38","author":"Illa","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0190","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/0022-510X(92)90217-9","article-title":"Antibodies to acidic glycolipids in Guillain-Barr\u00e9\u2019 syndrome and chronic inflammatory demyelinating polyneuropathy","volume":"107","author":"Ilyas","year":"1992","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.lpm.2013.01.058_bib0195","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/(SICI)1097-4598(200006)23:6<895::AID-MUS8>3.0.CO;2-G","article-title":"Anti-SGPG antibody in CIDP: a nosological position of IgM anti-MAG\/SGPG antibody-associated neuropathy","volume":"23","author":"Tagawa","year":"2000","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.058_bib0200","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","article-title":"Passive transfer of demyelination by serum or IgG from chronic inflamatory demyelinating polyneuropathy patients","volume":"47","author":"Yan","year":"2000","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0205","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.1129","article-title":"P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"50","author":"Yan","year":"2001","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0210","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/archneur.1980.00500590061010","article-title":"Immunoglobulin and complement deposits in nerves of patients with chronic relapsing polyneuropathy","volume":"37","author":"Dalakas","year":"1980","journal-title":"Arch Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0215","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1212\/WNL.30.8.864","article-title":"CSF monoclonal bands in chronic relapsing polyneuropathy","volume":"30","author":"Dalakas","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0220","doi-asserted-by":"crossref","first-page":"4788","DOI":"10.1073\/pnas.0807319106","article-title":"Impaired inhibitory Fcgamma receptor IIB expression on B-cells in chronic inflammatory demyelinating polyneuropathy","volume":"106","author":"Tackenberg","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2013.01.058_bib0225","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1529-8027.2011.00323.x","article-title":"CIDP-the relevance of recent advances in Schwanncell\/axonal neurobiology","volume":"16","author":"Pollard","year":"2011","journal-title":"J Peripheral Nervous System"},{"key":"10.1016\/j.lpm.2013.01.058_bib0230","doi-asserted-by":"crossref","first-page":"e14533","DOI":"10.1371\/journal.pone.0014533","article-title":"Nodes of Ranvier and paranodes in chronic acquired neuropathies","volume":"6","author":"Carmen Cifuentes-Diaz","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.lpm.2013.01.058_bib0235","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1093\/brain\/awn281","article-title":"Disruption of neurofascin and gliomedin at nodes of Ranvier precedes demyelination in experimental allergic neuritis","volume":"132","author":"Lonigro","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.lpm.2013.01.058_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","article-title":"Nodal proteins are target antigens in Guillain-Barr\u00e9 syndrome","volume":"17","author":"Devaux","year":"2012","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.058_bib0245","first-page":"288","article-title":"Antineurofascin antibodies are present in patients with peripheral demyelinating neuropathies and mediate changes in nerve conduction in animals","volume":"15","author":"Yan","year":"2010","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.058_bib0250","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1212\/WNL.0b013e31827689ad","article-title":"Neurofascin as a target for autoantibodies in peripheral neuropathies","volume":"79","author":"Ng","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0255","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1212\/WNL.0b013e3181bd1139","article-title":"Single nucleotide polymorphism of TAG-1 influences IVIg responsiveness of Japanese patients with CIDP","volume":"73","author":"Iijima","year":"2009","journal-title":"Neurology"},{"issue":"Suppl.\u00a015","key":"10.1016\/j.lpm.2013.01.058_bib0260","first-page":"S73","article-title":"Are anti-TAG-1 autoantibodies markers in autoimmune demyelinating disorders of the PNS and CNS?","volume":"70","author":"Alexopoulos","year":"2011","journal-title":"Ann Neurol"},{"issue":"P05","key":"10.1016\/j.lpm.2013.01.058_bib0265","first-page":"159","article-title":"Search for nodal and paranodal autoantibodies in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)","volume":"78","author":"Pavlakis","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0270","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.it.2003.12.004","article-title":"The Guillain-Barr\u00e9 syndrome: a true case of molecular mimicry","volume":"25","author":"Ang","year":"2004","journal-title":"Trends Immunol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0275","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/1097-0142(19890315)63:6<1166::AID-CNCR2820630621>3.0.CO;2-5","article-title":"Gangliosides of human melanoma","volume":"63","author":"Tsuchida","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/j.lpm.2013.01.058_bib0280","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1212\/WNL.46.3.822","article-title":"Chronic inflammatory demyelinating polyneuropathy associated with malignant melanoma","volume":"46","author":"Bird","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0285","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1212\/WNL.51.6.1738","article-title":"Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma","volume":"51","author":"Weiss","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0290","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/ana.410100109","article-title":"Polyneuropathy and monoclonal gammopathy: studies of 11 patients","volume":"10","author":"Dalakas","year":"1981","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0295","doi-asserted-by":"crossref","first-page":"7139","DOI":"10.1073\/pnas.78.11.7139","article-title":"Plasma cell dyscrasia and peripheral neuropathy: identification of the myelin antigens that react with human paraproteins","volume":"78","author":"Latov","year":"1981","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2013.01.058_bib0300","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1073\/pnas.81.4.1225","article-title":"IgM in a human neuropathy related to paraproteinemia binds to a carbohydrate determinant in the myelin-associated glycoprotein and to a ganglioside","volume":"81","author":"Ilyas","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2013.01.058_bib0305","doi-asserted-by":"crossref","first-page":"6697","DOI":"10.1073\/pnas.82.19.6697","article-title":"Polyneuropathy with monoclonal gammopathy: glycolipids are frequently antigens for IgM paraproteins","volume":"82","author":"Ilyas","year":"1985","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.lpm.2013.01.058_bib0310","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/ana.410310621","article-title":"Sensory neuropathy associated with monoclonal IgM to GD1b ganglioside","volume":"31","author":"Duane","year":"1992","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0315","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1172\/JCI118526","article-title":"Do antiganglioside antibodies cause human peripheral neuropathies?","volume":"97","author":"Quarles","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/j.lpm.2013.01.058_bib0320","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1056\/NEJM199003083221002","article-title":"Complement-dependent demyelination in patients with IgM monoclonal gammopathy and polyneuropathy","volume":"322","author":"Monaco","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.lpm.2013.01.058_bib0325","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/ana.20364","article-title":"IgM deposits on skin nerves in anti-myelin-associated glycoprotein neuropathy","volume":"57","author":"Lombardi","year":"2005","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0330","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1002\/mus.880111111","article-title":"Demyelination induced by intraneural injection of human anti-myelin-associated glycoprotein antibodies","volume":"11","author":"Willison","year":"1988","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.lpm.2013.01.058_bib0335","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1002\/ana.410330514","article-title":"Experimental paraprotein neuropathy; demyelination by passive transfer of human IgM anti-MAG","volume":"33","author":"Tatum","year":"1993","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0340","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1212\/WNL.61.6.736","article-title":"Practice parameter: immunotherapy for Guillain-Barr\u00e9 syndrome: report of the Quality Standards Subcommittee of the American Academy of Neurology","volume":"61","author":"Hughes","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0345","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(07)70329-0","article-title":"Intravenous immune globulin (10% caprylate-chromatography purified) for the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (ICE study): a randomised placebo-controlled trial","volume":"7","author":"Hughes","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0350","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/ana.410360607","article-title":"A plasma exchange versus immune globulin infusion trial in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"36","author":"Dyck","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0355","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/ana.410400516","article-title":"A controlled study of intravenous immunoglobulin in demyelinating neuropathy with IgM gammopathy","volume":"40","author":"Dalakas","year":"1996","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0360","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/ana.21577","article-title":"Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy","volume":"65","author":"Dalakas","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0365","first-page":"CD003280","article-title":"Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for CIDP","volume":"11","author":"Mahdi-Rodgers","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.lpm.2013.01.058_bib0370","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1212\/WNL.0b013e3181d1a862","article-title":"Intramuscular interferon beta-1a in chronic inflammatory demyelinating polyradiculoneuropathy","volume":"74","author":"Hughes","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.lpm.2013.01.058_bib0375","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S1474-4422(08)70299-0","article-title":"Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study","volume":"8","year":"2009","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0380","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2012.06832.x","article-title":"Biologics and other novel approaches as new therapeutic options in myasthenia gravis: a view to the future","volume":"1274","author":"Dalakas","year":"2012","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.lpm.2013.01.058_bib0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2013.03.006","article-title":"Novel future therapeutic options in Myasthenia Gravis","author":"Dalakas","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.lpm.2013.01.058_bib0390","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/ncpneuro0901","article-title":"B-cells as therapeutic targets in autoimmune neurological disorders","volume":"4","author":"Dalakas","year":"2008","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0395","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1177\/1756285609356135","article-title":"Practical considerations on the use of rituximab in autoimmune neurological disorders","volume":"3","author":"Kosmidis","year":"2010","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.lpm.2013.01.058_bib0400","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1136\/jnnp.2009.188912","article-title":"Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature","volume":"82","author":"Benedetti","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.lpm.2013.01.058_bib0405","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1001\/archneurol.2010.143","article-title":"Natalizumab treatment in a patient with chronic inflammatory demyelinating polyneuropathy","volume":"67","author":"Wolf","year":"2010","journal-title":"Arch Neurol"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.lpm.2013.01.058_bib0410","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1529-8027.2011.00311.x","article-title":"Potential biomarkers for monitoring therapeutic responses to IVIg and other therapies in CIDP","volume":"16","author":"Dalakas","year":"2011","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.lpm.2013.01.058_bib0415","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1002\/ana.21737","article-title":"Pharmacokinetics of intravenous immunoglobulin and outcome in Guillain-Barr\u00e9 syndrome","volume":"66","author":"Kuitwaard","year":"2009","journal-title":"Ann Neurol"},{"key":"10.1016\/j.lpm.2013.01.058_bib0420","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/ana.21784","article-title":"Inflammatory demyelinating polyneuropathy sera inhibit axonal growth of mouse dorsal root ganglion neurons by activation of rho-kinase","volume":"66","author":"Tanighuchi","year":"2009","journal-title":"Ann Neurol"}],"container-title":["La Presse M\u00e9dicale"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0755498213005125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T11:54:23Z","timestamp":1539690863000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0755498213005125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,6]]},"references-count":84,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["S0755498213005125"],"URL":"https:\/\/doi.org\/10.1016\/j.lpm.2013.01.058","relation":{},"ISSN":["0755-4982"],"issn-type":[{"value":"0755-4982","type":"print"}],"subject":[],"published":{"date-parts":[[2013,6]]}}}